Psagot Value Holdings Ltd. Abb Vie Inc. Transaction History

Psagot Value Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $69,085 - $87,829	502 Added 26.17%	2,420 $371,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $322,295 - $399,877	-2,442 Reduced 56.01%	1,918 $311,000
Q4 2021 Mar 14, 2022	BUY	$107.43 - $135.93 $354,519 - $448,569	3,300 Added 311.32%	4,360 $28,000
Q3 2021 Mar 07, 2022	BUY	$106.4 - $120.78 $112,784 - $128,026	1,060 New	1,060 $114,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

Stay updated on Psagot Value Holdings Ltd. with notifications on news.